Показано 0 из 0
Дата |
---|
30.06.2023 |
29.06.2023 |
28.06.2023 |
27.06.2023 |
26.06.2023 |
23.06.2023 |
22.06.2023 |
21.06.2023 |
20.06.2023 |
19.06.2023 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
8.20
|
8.03
|
8.31
|
8.25
|
|
|
799 752.00
|
|
|
|
8.70
|
8.21
|
8.82
|
8.30
|
|
|
703 177.00
|
|
|
|
8.80
|
8.35
|
8.82
|
8.44
|
|
|
623 766.00
|
|
|
|
8.10
|
7.84
|
8.68
|
8.61
|
|
|
1 514 119.00
|
|
|
|
8.05
|
7.78
|
8.10
|
7.96
|
|
|
340 223.00
|
|
|
|
7.87
|
7.87
|
8.12
|
7.91
|
|
|
435 305.00
|
|
|
|
7.99
|
7.71
|
8.03
|
7.92
|
|
|
574 298.00
|
|
|
|
8.82
|
7.61
|
8.94
|
7.93
|
|
|
2 467 470.00
|
|
|
|
10.22
|
8.65
|
10.50
|
8.72
|
|
|
3 983 582.00
|
|
|
|
8.69
|
8.65
|
9.04
|
8.95
|
|
|
371 838.00
|
|
Santhera Pharmaceuticals is a Swiss drug discovery and development company. It is focused on the development of treatments for neuromuscular and neuro-ophthalmological diseases that currently lack treatment options. The company was founded in 2004 through the merger of two start-up biotech companies, MyoContract and Graffinity Pharmaceuticals. Santhera’s headquarters are located in Liestal, Switzerland, with subsidiaries in Germany, UK, Italy, Netherlands, Liechtenstein, US and Canada.